Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy in a Phase III Randomized, Parallel Group Placebo Controlled Double Blind Multisite Field Trial

NCT05191186 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT05191186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05191186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy in a Phase III Randomized, Parallel Group Placebo Controlled Double Blind Multisite Field Trial
Lead sponsor
Aarhus University Hospital
Phase
Phase 3
Overall status
Completed
Start date
February 1, 2020
Completion date
December 31, 2023
Enrollment
450 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic asthma, allergic conjunctivitis of both eyes, allergic rhinitis due to grass pollen